UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): August 9, 2023

 

AVENIR WELLNESS SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-55908

 

90-1504639

(State or other jurisdiction

 

(Commission

 

(IRS Employer

of incorporation)

 

File Number)

 

Identification No.)

 

5805 Sepulveda Blvd., Suite 801

Sherman Oaks, California

 

91411

(Address of principal executive offices)

(Zip Code)

 

 (424) 273-8675

(Registrant’s telephone number, including area code)

 

__________________________________________________

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act: None.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

Item 8.01 Other Events.

 

As previously announced, on October 14, 2022, Avenir Wellness Solutions, Inc. (the “Company”), a Delaware corporation formerly known as CURE Pharmaceutical Holding Corp., changed its name from “CURE Pharmaceutical Holding Corp.” to “Avenir Wellness Solutions, Inc.” On August 8, 2023, the Company was notified by the Financial Industry Regulatory Authority Inc. (“FINRA”) that it approved the Company’s ticker symbol change from “CURR” to “AVRW,” with an effective date of August 9, 2023, and that such ticker symbol change and effective date had been announced on FINRA’s Daily List on August 8, 2023. The Company’s CUSIP number remains 23127P104.

 

On August 8, 2023, the Company issued a press release announcing, among other things, its receipt of regulatory approval to change its ticker symbol to “AVRW,” such change to be effective at the stock market opening of August 9, 2023. A copy of such press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Number

 

Description

99.1

 

Press Release, dated August 8, 2023

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

AVENIR WELLNESS SOLUTIONS, INC.

 

 

 

 

Date: August 11, 2023

By:

/s/ Joel Bennett

 

 

Name: 

Joel Bennett

 

 

Title:

Chief Financial Officer

 

 

 
3

 

nullv3.23.2
Cover
Aug. 09, 2023
Cover [Abstract]  
Entity Registrant Name AVENIR WELLNESS SOLUTIONS, INC.
Entity Central Index Key 0001643301
Document Type 8-K
Amendment Flag false
Entity Emerging Growth Company false
Document Period End Date Aug. 09, 2023
Entity Incorporation State Country Code DE
Entity Tax Identification Number 90-1504639
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Entity File Number 000-55908
Entity Address Address Line 1 5805 Sepulveda Blvd.
Entity Address Address Line 2 Suite 801
Entity Address City Or Town Sherman Oaks
Entity Address State Or Province CA
Entity Address Postal Zip Code 91411
City Area Code 424
Local Phone Number 273-8675
Cure Pharmaceutical (PK) (USOTC:CURR)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Cure Pharmaceutical (PK) Charts.
Cure Pharmaceutical (PK) (USOTC:CURR)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Cure Pharmaceutical (PK) Charts.